Clinical trials
Observational Hodgkin Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 5 |
| Recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 4 |
| Fondazione Italiana Linfomi - ETS | 3 |
| Gruppo Italiano Studio Linfomi | 2 |
| Ospedale Santa Croce-Carle Cuneo | 2 |
| A.O. Ospedale Papa Giovanni XXIII | 1 |
| A.O.U. Città della Salute e della Scienza | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Federico II University | 1 |
| Gruppo Italiano Malattie EMatologiche dell'Adulto | 1 |
| Ospedale Maggiore Di Trieste | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 19 |
| Lymphoma | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Breast Neoplasms | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Blast Crisis | 1 |
| Breast Carcinoma In Situ | 1 |
| Breast Neoplasms, Male | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.